111In-ibritumomab tiuxetan
Term · Oncology and biomedicine · MLC-T-ONC-000002
A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-ibritumomab tiuxetan is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-ibritumomab tiuxetan. 111In-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan.
| Identifier | MLC-T-ONC-000002 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 111In-Zevalin; indium In 111-ibritumomab tiuxetan |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000002",
"term": "111In-ibritumomab tiuxetan",
"field": "Oncology and biomedicine",
"definition": "A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-ibritumomab tiuxetan is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-ibritumomab tiuxetan. 111In-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan.",
"synonyms": [
"111In-Zevalin",
"indium In 111-ibritumomab tiuxetan"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/111in-ibritumomab-tiuxetan/"
}
Record 2 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.